Facebook
Twitter
Telegram
Report an ErrorDeciphera Pharmaceuticals Financial Statements 2011-2024 | DCPH
Annual Financial Statements Deciphera Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.2 B | 1.24 B | 448 M | 2.44 B | 2.74 B | 933 M | 443 M | - | - | - | - | - | - |
Shares |
85.1 M | 75.5 M | 58.1 M | 55.8 M | 42.9 M | 35.4 M | 16.8 M | - | - | - | - | - | - |
Historical Prices |
14.1 | 16.4 | 7.71 | 43.8 | 53.2 | 28.4 | 25 | - | - | - | - | - | - |
Net Income |
-195 M | -179 M | -300 M | -266 M | -192 M | -99.9 M | -50.3 M | -25.9 M | -19.8 M | - | - | - | - |
Revenue |
163 M | 134 M | 96.1 M | 42.1 M | 25 M | - | - | - | - | - | - | - | - |
Cost of Revenue |
3.73 M | 8.77 M | 2.93 M | 225 K | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-211 M | -183 M | -300 M | -271 M | -201 M | -104 M | -50.9 M | -25.8 M | -17.6 M | - | - | - | - |
Interest Expense |
16.4 M | 4.51 M | 113 K | 4.7 M | 67 K | 84 K | 95 K | 106 K | 2.21 M | - | - | - | - |
EBITDA |
-209 M | -180 M | -297 M | -269 M | -200 M | -104 M | -50.8 M | -25.7 M | -17.5 M | - | - | - | - |
Operating Expenses |
- | - | - | - | 226 M | 104 M | 50.9 M | - | - | - | - | - | - |
General and Administrative Expenses |
136 M | 120 M | 136 M | 114 M | 68.1 M | 21.2 M | 11.4 M | 5.68 M | 5.14 M | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Deciphera Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
85.8 M | 85 M | 82.7 M | 67.6 M | 78.2 M | 72.1 M | 58.6 M | 58.5 M | 58.1 M | 58 M | 57.7 M | 57.6 M | 56.4 M | 55.9 M | 53.6 M | 51.6 M | 43.8 M | 38.2 M | 38.1 M | 37.7 M | 37.7 M | 33.6 M | 32.6 M | 32.6 M | 11.6 M | 11.6 M | 11.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-49.6 M | -48.6 M | -49.6 M | - | -43 M | -43.1 M | -46.9 M | - | -79.8 M | -70.4 M | -300 M | -62.7 M | -266 M | -266 M | -266 M | -67.2 M | -192 M | -192 M | -192 M | -32.3 M | -99.9 M | -99.9 M | 99.9 M | -19.9 M | -50.3 M | -50.3 M | -50.3 M | -8.56 M | -6.1 M | -5.93 M | -5.35 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
43.3 M | 38.3 M | 33.4 M | - | 36 M | 32.5 M | 29.2 M | - | 23.2 M | 23.6 M | 25.2 M | 19.5 M | 15.4 M | 7.09 M | 62 K | - | - | 25 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
1.29 M | 173 K | 488 K | - | 3.34 M | 1.8 M | 382 K | - | 917 K | 1.28 M | 222 K | - | 90 K | 8 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | 19.4 M | 15.4 M | 7.08 M | 62 K | - | - | 25 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-53.7 M | -52.8 M | -53.3 M | - | -44.9 M | -43.8 M | -46.9 M | - | -79.7 M | -70.5 M | -61.5 M | -63 M | -64 M | -68.9 M | -75.3 M | -70.4 M | -58.4 M | -23 M | -49 M | -33.8 M | -25.9 M | -22.4 M | -22 M | -20.3 M | -12.2 M | -10.7 M | -7.72 M | -8.53 M | -6.07 M | -5.91 M | -5.32 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
4.11 M | 4.21 M | 3.65 M | - | 1.84 M | 727 K | - | - | -170 K | 81 K | 196 K | - | - | - | - | - | 17 K | 25 K | 13 K | - | 21 K | 21 K | 22 K | - | 23 K | 24 K | 25 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -52.6 M | - | -42.5 M | -43.8 M | -46.1 M | - | -77.4 M | -70.5 M | -60.8 M | -63 M | -62.4 M | -68 M | -74.8 M | -70.4 M | -58 M | -22.8 M | -48.9 M | -33.8 M | -25.7 M | -22.3 M | -21.9 M | -20.3 M | -12.1 M | -10.6 M | -7.69 M | -8.53 M | -6.07 M | -5.91 M | -5.32 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 75.3 M | - | 58.4 M | 48 M | 49 M | - | 25.9 M | 22.4 M | 22 M | - | 12.2 M | 10.7 M | 7.73 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
33.3 M | 32.6 M | 31.4 M | - | 30 M | 29.6 M | 28.3 M | - | 35.5 M | 32.8 M | 30.7 M | - | 30.1 M | 29.9 M | 23.9 M | - | 18 M | 13.2 M | 13.2 M | - | 5.26 M | 4.45 M | 5.03 M | - | 2.43 M | 2.24 M | 2.07 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency